Quality Improvement: Advancing Guideline-Directed Care in Hypertrophic Cardiomyopathy |
|
Genetic testing is increasingly important in determining potential cardiac conditions in patients and is used in clinical settings more than ever before. To ensure that physicians have up-to-date knowledge of the evolving role of genetic testing for identifying predisposition for genetic heart disease and sudden death, which can be lifesaving for some patients, the Heart Rhythm Society developed a webinar to increase awareness and adoption of guideline directed care for the diagnosis and treatment of patients with hypertrophic cardiomyopathy (HCM).
Faculty: Bruce Stambler, MD, FHRS Electrophysiologist, Piedmont Heart Institute Suneet Mittal, MD, Director Electrophysiology Lab, The Valley Hospital Jose Joglar, MD Professor of Medicine, UT Southwestern Med. Ctr. Dall Elizabeth McNally, MD, PhD Elizabeth Ward Professor and Director Center for Genetic Medicine, Northwestern University Brittney A. Murray, MS Genetic Counselor, Johns Hopkins Hospital Katherine G. Spoonamore, MS, CGC Genetic Counselor, Indiana University/Krannert Institute HRS365 Course: https://www.heartrhythm365.org/Public/Catalog/Details.aspx?id=qryHPz59EwjbKPATdvtwGg%3d%3d&returnurl=%2fUsers%2fUserOnlineCourse.aspx%3fLearningActivityID%3dqryHPz59EwjbKPATdvtwGg%253d%253d |